Tazobactam Sodium

他唑巴坦钠

Report date: 2022/05/12 17:20:13
NME

Base Information

Drug NameTazobactam Sodium
Drug Alias Name三唑巴坦钠他唑巴坦YTR-830HCL-307579
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTaiho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLivzon Syntpharm Co Ltd (Zhuhaiftz)
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01CG02
Related LinksWikipediaDrugBankKEGG